Cantor Fitzgerald reiterated its Overweight rating on ORIC Pharmaceuticals (NASDAQ:ORIC), currently trading at $13.39, after an incident involving a potential news leak. According to InvestingPro data ...

Savita Dandapani, MD, PhD, discusses the rationale behind a study evaluating the combination of radium-223, hormone therapy, and SBRT in metastatic castration-sensitive prostate cancer.

As you navigate the challenges of prostate cancer and erectile dysfunction, remember that you are not alone. With advances in ...

Robert F Kennedy Jr has left social media users scratching their heads after the Health and Human Services secretary nominee ...

The pharma giant hosted its ninth annual Blue Jacket Fashion Show in collaboration with designer Frederick Anderson in New ...

The Ghana Health Service (GHS) has said that prostate and liver cancers are among the leading causes of death in the country ...

Trusted source of information on Prostate Health that includes articles, news, videos, animations, quizzes, calculators and ...

A new urine test may allow men to screen for prostate cancer at home in the future. A woman described her battle with pain ...